P

Inventor

PLAYER MARK R

US32 patents
⚠️ This page may combine multiple inventors who share the name “PLAYER MARK R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

24 patents
US7608622B2Oct 27, 2009

Imidazo[4,5-b]pyrazinone inhibitors of protein kinases

JANSSEN PHARMACEUTICA NV53 citations96
US7790724B2Sep 7, 2010

c-fms kinase inhibitors

JANSSEN PHARMACEUTICA NV26 citations90
US9067898B1Jun 30, 2015

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV13 citations84
US7829584B2Nov 9, 2010

Pyridines and pyridine N-oxides as modulators of thrombin

JANSSEN PHARMACEUTICA NV12 citations81
US9920040B2Mar 20, 2018

GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV2 citations73
US9908873B2Mar 6, 2018

GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV2 citations73
US9856245B2Jan 2, 2018

GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV2 citations73
US9193736B2Nov 24, 2015

PDE 10a inhibitors for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV7 citations72
US7326788B2Feb 5, 2008

Quinolinone derivatives as inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV8 citations71
US9718820B2Aug 1, 2017

Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators

JANSSEN PHARMACEUTICA NV1 citations60
US7951829B2May 31, 2011

Benzimidazole modulators of VR1

JANSSEN PHARMACEUTICA NV6 citations60
US10988433B2Apr 27, 2021

Cyclohexyl GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US10662170B2May 26, 2020

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US10131648B2Nov 20, 2018

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US9790198B2Oct 17, 2017

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations52
US9409915B2Aug 9, 2016

Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

JANSSEN PHARMACEUTICA NV0 citations49
US9023846B2May 5, 2015

Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

JANSSEN PHARMACEUTICA NV0 citations49
US7642270B2Jan 5, 2010

5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV1 citations49
US10106553B2Oct 23, 2018

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations41
US9688642B2Jun 27, 2017

Substituted pyrazines as GPR40 agonists

JANSSEN PHARMACEUTICA NV0 citations41
US9249163B2Feb 2, 2016

PDE10a inhibitors for the treatment of type II diabetes

JANSSEN PHARMACEUTICA NV0 citations40
US7612211B2Nov 3, 2009

Benzimidazole TRPV1 inhibitors

JANSSEN PHARMACEUTICA NV0 citations39
US7446210B2Nov 4, 2008

Factor Xa compounds

JANSSEN PHARMACEUTICA NV0 citations39
US7728003B2Jun 1, 2010

5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase

JANSSEN PHARMACEUTICA NV0 citations36

ORTHO MCNEIL PHARM INC

2 patents

PLAYER MARK R

2 patents

US HEALTH

1 patent

DIMENSIONAL PHARM INC

1 patent

MEDERSKI WERNER

1 patent

CALVO RAUL R

1 patent